Dr. Rutherford completed his Ph.D. and M.D. at Medical College of Ohio at Toledo, residency in Cooper Hospital/University Medical Center, Robert Wood Johnson Medical School.  He completed his fellowship in gynecologic oncology at Yale University School of Medicine in 1995. He is currently an Associate Professor and Division Director for the Section of Gynecologic Oncology at Yale University and Yale New Haven Hospital.   He has been awarded the Nathan Kase award from the Resident Education program for Teaching, along with multiple Top Physician Awards both in Connecticut and New York.  He has authored more than 20 original articles and several book chapters and review articles. He is actively involved in research, serving as the principal investigator for the Gynecologic Oncology Group (GOG) clinical trials protocols in the section, and as principal investigator or co–investigator on multiple other protocols. His area of focus involves the treatment of pre–malignant and malignant gynecologic disorders involving the vulva, cervix, vagina, uterus, ovaries, fallopian tubes, and placenta.  He has a very active clinical practice in Gynecologic Oncology.  He emphasizes the importance of minimally invasive approaches for gynecologic cancer.  He directs numerous clinical trials and is active in basic research.  He is board certified in both Obstetrics and Gynecology and in Gynecologic Oncology.  He is a reviewer for multiple peer–reviewed journals, including Gynecologic Oncology and Cancer.

Dr. Azodi completed his undergraduate, graduate, medical school and Ob/Gyn residency training in Ohio. He then completed his fellowship in gynecologic oncology at Yale in 1996. He is currently an associate professor in the Section of Gynecologic Oncology. He also serves as Chief of Gynecologic Oncology at Bridgeport hospital and Director of Microinvasive and Robotic Surgery at Yale Gynecologic Oncology. He has been awarded the CREOG National Faculty Award for Excellence in Resident Education four times, and has also been the recipient of the Association of Professors of Gynecology and Obstetrics Excellence in Teaching Award. He has authored more than 20 original articles and several book chapters and review articles. He is actively involved in research, serving as the co–principal investigator for all of the Gynecologic Oncology Group (GOG) clinical trials protocols in the section, and as principal investigator or co–investigator on multiple other protocols. He researches and lectures on treatment options for pre–malignant and malignant gynecologic disorders involving the vulva, cervix, vagina, uterus, ovaries, fallopian tubes, and placenta. Dr. Azodi emphasizes the importance of minimally invasive approaches for gynecologic cancer. This includes laparoscopic staging, radical vaginal surgery and radical trachelectomy. He has performed multiple successful radical trachelectomies for cervical cancer management with preservation of reproductive potential. He has performed many laparoscopic surgeries for management of gynecologic diseases, including more than 300 robotic–assisted cases. He is a reviewer for multiple peer–reviewed journals, including Gynecologic Oncology and Cancer. He is board certified in both Obstetrics and Gynecology and in Gynecologic Oncology.

Among his honors, he received the American Association of Cancer Research’s Young Investigator Award and the Italian Society of Gynecologic Oncologists Award for Translational Science.

Dr. Santin’s clinical interests include cancer of the ovary, uterus, vagina, cervix and vulva; intraperitoneal chemotherapy, tumor immunoloyg and immunotherapy; and tumor angiogenesis, radiation biology, and experimental therapeutics in gynecologic oncology.